Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants

Journal of Neonatal-Perinatal Medicine

Volumn 7, Issue 3, 2014, Pages 229-235

  ElHassana, Nahed O ^a   Bird, T M ^b   King, A J ^c   Ambadwar, P B ^d   Jaquiss, R D B ^e   Kaiser, J R ^f   Robbins, J M ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MAYO CLINIC   (United States)

^e DUKE CHILDREN S HOSPITAL   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Extremely low birth weight infants; Ibuprofen; Indomethacin; Patent ductus arteriosus

Indexed keywords

IBUPROFEN; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BRAIN HEMORRHAGE; COMPARATIVE EFFECTIVENESS; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; INTESTINE SURGERY; KIDNEY FAILURE; LEUKOMALACIA; LIGATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PERIVENTRICULAR LEUKOMALACIA; PERSISTENT PULMONARY HYPERTENSION; PHARMACEUTICAL CARE; COHORT ANALYSIS; COMPARATIVE STUDY; DUCTUS ARTERIOSUS, PATENT; EVALUATION STUDY; INFANT, PREMATURE, DISEASES; PREMATURITY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

COHORT STUDIES; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84909943599     PISSN: 19345798     EISSN: 18784429     Source Type: Journal    
DOI: 10.3233/NPM-14814015     Document Type: Article

References (29)

1. Noori S. Patent ductus arteriosus in the preterm infant: To treat or not to treat? J Perinatol 2010;30:S31-7.
2. Oh W, Poindexter BB, Perritt R, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005;147:786-90.
3. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000;137:68-72.
4. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F183-6.
5. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: A population-based study. J Pediatr Gastroenterol Nutr 2005;40:184-8.
6. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: Time to accept the null hypothesis? J Perinatol 2010;30:241-52.
7. Sekar KC, Corff KE. Treatment of patent ductus arteriosus: Indomethacin or ibuprofen. J Perinatol 2008;28:S60-2.
8. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: A randomized pilot study. Am J Perinatol 2007;24:267-70.
9. Chotigeat U, Jirapada K, Laryangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003;86:S563-9.
10. Hammerman C, Shchors I, Jacobson S, et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: Is the difference in the mode of administration? Pediatr Res 2008;64:291-7.
11. Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: A randomized controlled trial. Eur J Pediatr 2002;161:202-7.
12. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42.
13. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-8.
14. Salama H, Alsisi A, Al-Rifai H, et al. A randomized controlled trial on the use of oral ibuprofen to close patent ductus arteriosus in premature infants. J Neonatal Perinatal Med 2008;1:153-8.
15. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC. Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: A randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 2008;93:F94-9.
16. Kiefer AS, Wickremasinghe AC, Johnson JN, et al. Medical management of extremely low-birth-weight infants in the first week of life: A survey of practices in the United States. Am J Perinatol 2009;26:407-18.
17. Fletcher DM. Achieving data quality. How data from a large pediatric health information system earns the trust of its users. J AHIMA 2004;75:22-6.
18. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009;338:b2393.
19. Terza JV, Bradford WD, Dismuke CE. The use of linear instrumental variables methods in health services research and health economics: A cautionary note. Health Serv Res 2008;43:1102-20.
20. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010;19:537-54.
21. Erdeve O, Yurttutan S, Altug N, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: A randomized controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2012;97:F279-83.
22. Yurttutan S, Oncef MY, Arayici S, et al. A different first choice drug in the medical management of patent ductus arteriosus: Oral paracetamol. J Matern Fetal Neonatal Med 2013;26:835-7.
23. Rao R, Bryowsky K, Mao J, Bunton D, McPherson C, Mathur A. Gastrointestinal complications associated with ibuprofen for patent ductus arteriosus. J Perinatol 2011;31:465-70.
24. Katakam LI, Cotton CM, Goldberg RN, Dang CN, Smith PB. Safety and effectiveness of indomethacin versus ibuprofen for treatment of the patent ductus arteriosus. Am J Perinatol 2010;27:425-9.
25. Gournay V, Roze JC, Daoud P, et al. Prophylactic ibuprofen versus placebo in very premature infants: A randomized, double-blind, placebo-controlled trial. Lancet 2004;364:1939-44.
26. Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011;96:F45-52.
27. Koch J, Hensley G, Roy L, Bown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113-21.
28. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database 2013; Syst Rev 4:CD003481. doi: 10.1002/14651858.CD003481.pub5.
29. Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very low birth weight infants with symptomatic patent ductus arteriosus. J Pediatr 1983;103:979-84.